Print

neoClose From neoSurgical Limited Recognized as a 2013 Innovation of the Year by the Society of Laparoendoscopic Surgeons  
8/28/2013 10:26:25 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DUBLIN, IRELAND and CHICAGO, IL--(Marketwired - August 28, 2013) -

neoSurgical, an international medical device company focused on advancing safer, simpler and superior solutions for Laparoscopic and Minimally Invasive Surgery (MIS), announces today that its newest product, neoClose™, has been selected by the Society of Laparoendoscopic Surgeons (SLS) as one of the 2013 Innovations of the Year. The recognition will be presented during the SLS Minimally Invasive Surgery Week Annual Meeting and Endo Expo 2013 on August 28 at the Hyatt Regency Reston in Reston, VA.

In trying to complete wound closure after Laparoscopic surgery, surgeons have continually grappled with locating sutures within the abdomen as well as managing post-operative complications of not doing so effectively. neoClose, an innovative new FDA-approved device is designed to quickly, simply and effectively close any port or access site in the abdominal wall following Laparoscopic (keyhole) surgery. The device delivers two absorbable AutoAnchors™, consisting of a suture and an anchor assembly, whereby the sutures are reliably placed for ease of closure. Compared to more traditional methods, this method offers reduced tension at wound sites, potentially leading to reduced pain and lower risk of herniation following surgery. Surgeons have found the design to be very intuitive and simple for locating sutures within the abdomen to affect a very secure hassle free, time saving port closure. The device is so easy to use that it can be deployed under full pneumo/inflation in three simple steps in under one minute.

"It's truly an honor for neoClose to be recognized by SLS as one of their surgical innovations for 2013," said Barry Russell, neoSurgical Founder and CEO. "neoSurgical is focused on engineering world-class innovative devices to assist Laparoscopic surgeons deliver better outcomes in this rapidly growing surgical arena. There's great interest in Laparoscopic techniques that result in faster recovery time, reduced pain and post-operative complications. Our research estimates that there are up to 7 million Laparoscopic wound sites requiring closure in the US each year. On top of this, the segment has a compound annual growth rate (CAGR) of 9.2 percent. These robust numbers indicate a promising future for devices that can deliver cost-effective, simple, safe and superior performance to benefit the Laparoscopic surgeon and their patients," he added.

According to Dr. Philip L. Leggett M.D FACS, Director of the Laparoendoscopic Fellowship, University of Texas at Houston Northwest Medical Center, "neoClose has proven to me that it can deliver reliable and effective outcomes for the common challenges associated with port closures following Laparoscopic surgery. I've observed that neoClose can deliver superior performance for me and my patients reducing concerns for post-operative complications. In my view this device has a particularly useful application in the delivery of care to Bariatric/Obese patients, many of whom I see at my practice."

Each year SLS recognizes the most innovative products of the past year that have a multi-disciplinary application in minimally invasive surgery. Innovations of the Year are announced at the SLS Minimally Invasive Surgery Week Annual Meeting and Endo Expo. The selection of products is for informational purposes only and does not constitute an endorsement or approval by SLS. Surgeons should investigate any new equipment for safety and suitability for their particular practice and needs.

About neoSurgical

neoSurgical is a global medical device company focused on providing technical innovation to the surgical devices industry, particularly for those surgeons conducting laparoscopic and minimally invasive surgery (MIS). neoSurgical leverages its in-depth expertise in interpreting surgeons' needs and converting these needs via an innovative and market led engineering response to deliver compliant devices with the goal to make surgery safer, simpler and superior for both surgeons and their patients. The company's European headquarters is in Dublin with U.S. headquarters in Chicago. More information about neoSurgical can be found at: www.neosurgical.com.

About SLS

The Society of Laparoendoscopic Surgeons was established as an educational, non-profit organization to help ensure the highest standards for the practice of laparoscopic, endoscopic and minimally invasive surgery. The Society serves surgeons from various specialties and other health professionals who are interested in advancing their expertise in the diagnostic and therapeutic uses of Laparoendoscopic and minimally invasive surgical techniques. With an international membership of over 6,000 surgeons, the organization offers a unique approach to the study and education of minimally invasive surgery by bringing together different medical specialties that use the techniques and tools of minimally invasive surgery.


Media Contact:
Valerie Harding
Ripple Effect Communications
617-536-8887
Email Contact

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:



Help employers find you! Check out all the jobs and post your resume.

//-->